We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
Details of the Yellow Card scheme, which is the system for recording adverse incidents with medicines and medical devices in the UK.
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
The following guidance has been jointly developed by the Heath Research Authority (HRA) and MHRA, in consultation with the Information Commissioners Office (ICO), on behalf of the UK.
Actions that trial sponsors should consider to build resilience into clinical trial design
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
As an owner or manager of land in the coastal margin, find out about your responsibilities and how to manage public access.
How to use a before-and-after study to evaluate your digital health product.
Helping public health practitioners conducting evaluations – developing a logic model to represent how your intervention works.
Following a review, the MHRA has updated previous guidance (DSI/2022/003) on the use of paclitaxel coated devices (PCD) in the treatment of peripheral arterial disease (PAD).
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
A payment approach that has the potential to drive greater collaboration between all services within an urgent and emergency care network.
Capitation is an example of a potential new payment model to enable integrated care.
How to use an economic evaluation to evaluate your digital health product.
Supporting health and care professionals to improve services by better understanding the health outcomes that some people in the Roma community face.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.